Delivery Order SPE2DB20D3303-SPE2DB25FA1LM
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,029.98 Firm Fixed Price delivery order contract is for the supply of 16,000 unit capsules of the drug PERTZYE DR. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- This federal contract award is for the delivery of 16,000 units of the medication PERTZYE DR 16,000 UNIT CAPSULE to the Defense Logistics Agency (DLA), a defense agency. The $26,094.23 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 13, 2024, with a completion date of March 14, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,144.30 firm fixed price delivery order contract is for the supply of 24,000 units of the prescription drug PERTZYE DR 200S. The contract has an ultimate completion date of July 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,242.46, is for the delivery of 24,000 units of the prescription medication PERTZYE DR 80S. The contract is a firm fixed-price, non-set-aside award with a performance period through July 2025. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,731.10 firm fixed price delivery order is for the supply of 16,000 units of the pharmaceutical product PERTZYE DR 16,000 UNIT CAPSULE UU 100S. This award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $9,016.84 firm fixed-price delivery order is for the supply of 24,000 units of the pharmaceutical product Pertzye DR 24,000 Unit Capsule. This award is not designated as a set-aside contract. The contract has an ultimate completion date of June 6, 2025 and was awarded on June 5,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 units of PERTZYE DR 100S capsules, with a firm fixed price ceiling value of $24,368.76. The ultimate completion date for this delivery order is May 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,464.59 firm fixed-price delivery order is for 16,000 units of the drug Pertzye, a specialty medication used to treat pancreatic enzyme deficiency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 unit capsules of the medication Pertzye DR, a pancreatic enzyme replacement therapy, at a firm fixed price of $10,241.07. The contract has an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, with an ID of SPE2DB22D1002|SPE2DB25FKVP9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 24,000 units of the medication Pertzye DR 24,000 unit capsule, with a total ceiling value of $21,261.41. This is a delivery order contract with a firm fixed price pricing type. The contract has a period of performance through December 17,...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1LMDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $8,136.80 with a firm fixed price for the delivery of 24,000 units of the medication PERTZYE DR 80S capsule. The contract has an ultimate completion date of July 18, 2025 and was awarded on July 17, 2025. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 7/17/25 |